Xue-Li Zhang (Xueli Zhang)

Years Active: 2019-2023
Publications (10 Years): 4

This page only lists publications with an associated author ORCID identifier.

Publications

Qian-Wen Zheng, Qian-Zhi Ni, Bing Zhu, Xin Liang, Ning Ma, Yi-Kang Wang, Sheng Xu, Hui-Jun Cao, Ji Xia, Feng-Kun Zhang, Er-Bin Zhang, Xiao-Song Qiu, Xu-Fen Ding, Lin Qiu, Xi-Lin Zhang, Zhao-Hui Dong, Zhi-Gang Li, Xue-Li Zhang, Dong Xie, Jing-Jing Li
Correction to: PPDPF promotes lung adenocarcinoma progression via inhibiting apoptosis and NK cell-mediated cytotoxicity through STAT3. Oncogene (2023)
Qian-Wen Zheng, Qian-Zhi Ni, Bing Zhu, Xin Liang, Ning Ma, Yi-Kang Wang, Sheng Xu, Hui-Jun Cao, Ji Xia, Feng-Kun Zhang, Er-Bin Zhang, Xiao-Song Qiu, Xu-Fen Ding, Lin Qiu, Xi-Lin Zhang, Zhao-Hui Dong, Zhi-Gang Li, Xue-Li Zhang, Dong Xie, Jing-Jing Li
PPDPF promotes lung adenocarcinoma progression via inhibiting apoptosis and NK cell-mediated cytotoxicity through STAT3. Oncogene 41 (36) (2022)
Gaigai Wei, Na Gao, Jiwei Chen, Lingling Fan, Zhiyang Zeng, Ganglong Gao, Liang Li, Guojiu Fang, Kewen Hu, Xiufeng Pang, Heng-Yu Fan, Hans Clevers, Mingyao Liu, Xue-Li Zhang, Dali Li
Erk and MAPK signaling is essential for intestinal development through Wnt pathway modulation. Development (Cambridge, England) 147 (17) (2020)
Qin-Cheng Liu, Wei Zhang, Zhenqian Wu, Haijun Liu, Huiqiong Hu, Huisen Shi, Shaohua Li, Xue-Li Zhang
Construction of a circular RNA-microRNA-messengerRNA regulatory network in stomach adenocarcinoma. Journal of cellular biochemistry 121 (2) (2019)

Xue-Li Zhang.css-eqlu8i{font-size:small;padding-left:4px;} (Xueli Zhang)